⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

October 1, 2016HepatoBiliary Surgery and NutritionOpen Access

Immune surveillance of liver cancer in non-alcoholic fatty liver disease: excess lipids cause CD4 T-cells loss and promote hepatocellular carcinoma development

Ralf Weiskirchen Frank Tacke

View Full Paper

Ask AI

Bookmark

Share

Abstract

Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in industrialized countries with an increasing prevalence worldwide (1).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Weiskirchen et al. (2016) studied this question.

synapsesocial.com/papers/6a97f499161d47660415e9ff https://doi.org/10.21037/hbsn.2016.09.10

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1When a suspicious liver lesion is not cancer: primary hepatic myopericytoma in chronic hepatitis BHepatoBiliary Surgery and Nutrition · Tue,
2An artificial intelligence-augmented electrocardiogram model can detect undiagnosed chronic liver disease, but can this be applied in primary care?HepatoBiliary Surgery and Nutrition · Tue,
3Biliary and respiratory complications after right hepatectomy for hepatocellular carcinoma following selective internal radiation therapy (SIRT): a retrospective case-control studyHepatoBiliary Surgery and Nutrition · Wed,
4Efficacy of hepatic arterial infusion chemotherapy in advanced hepatocellular carcinoma: survival outcomes and prognostic factors from a systematic review and meta-analysisHepatoBiliary Surgery and Nutrition · Wed,
5Laparoscopic versus robotic pancreaticoduodenectomy for distal cholangiocarcinoma after learning curves of surgeons: a multicenter propensity score-matched studyHepatoBiliary Surgery and Nutrition · Mon,

More from HepatoBiliary Surgery and Nutrition

Sequential hepatectomy for hepatocellular carcinoma with inadequate future-liver-remnant after portal vein ligation in combination with apatinib plus camrelizumab (PLACES): a single-arm prospective pilot studyTue,
Plasma GLP-1 and metabolic dynamics during human liver regeneration and their association with posthepatectomy liver failureMon,
2024 latest report on hepatitis B virus epidemiology in China: current status, changing trajectory, and challengesMon,
Deciphering molecular crosstalk mechanisms between skeletal muscle atrophy and KRAS-mutant pancreatic cancer: a literature reviewMon,
Predictive model for very early recurrence of patients with perihilar cholangiocarcinoma: a machine learning approachMon,